NOVARTIS PHARMS CORP N 16366Letterhttp://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022059s001ltr.pdf0220590014/27/2007 12:00:00 AMSLRLabeling Revision022059001TABLET;ORALEQ 250MG BASE11TYKERBLAPATINIB DITOSYLATE